mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
9e-05 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
bendamustine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
mRNA |
PI-103 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0002 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
CX-5461 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0003 |